Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study.
BACKGROUND AND OBJECTIVE Interstitial lung disease (ILD) is the leading cause of mortality in inflammatory myopathies (IIM). We evaluated serum Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for IIM-associated ILD. MATERIAL AND METHODS Single-centre prospective cohort of 54 consecutive adults...